S B Ross
Index: Pharmacol. Toxicol. 76(2) , 141-5, (1995)
Full Text: HTML
The characteristics of the binding of 3H-proadifen to rat liver membranes were studied and compared to those of 3H-cocaine. It was found that 3H-proadifen was bound reversibly with high affinity (KD = 1.8 +/- 0.5 nM) and large capacity (Bmax = 2010 +/- 340 pmol/g wet tissue) to liver membranes. The corresponding values for the 3H-cocaine binding were 3.5 nM and 1000 pmol/g wet tissue. The binding of 3H-proadifen was mainly localised to the microsomal fraction. The number of binding sites was not increased by treatment of rats with phenobarbitone. With 1 microM CdCl2 in the incubation buffer it was possible to differentiate between two 3H-cocaine binding sites with Kd values of 1.6 and 7.7 nM and Bmax values of 280 and 940 pmol/g wet liver tissue. S-(-)-Alaproclate inhibited the binding of 3H-proadifen and 3H-cocaine with high affinity (IC50 = 2.2 nM and 0.4 nM, respectively). The R-enantiomer was 100 to 300 times less potent. Cocaine inhibited the binding of 3H-proadifen (IC50 = 10 nM) and proadifen that of 3H-cocaine (IC50 = 1 nM). There was a high correlation coefficient (rr = 0.972; P < 0.01; n = 12) in the Spearman rank test between the inhibitory potencies of compounds examined in both systems. Besides some potent alaproclate analogues a couple of compounds had moderately high affinity (IC50 = 100-500 nM): chloroquine, phenoxybenzamine, amitriptyline, ajmaline, remoxipride, imipramine and (-)-alaprenolol. CdCl2, ZnCl2 and CuCl2 inhibited the binding of both ligands with low Hill coefficients, indicating heterogeneous binding sites.(ABSTRACT TRUNCATED AT 250 WORDS)
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Alaproclate HCl
CAS:60719-83-7 |
C13H19Cl2NO2 |
The effects of increased serotonergic and decreased choliner...
1991-05-01 [Pharmacol. Biochem. Behav. 39(1) , 25-9, (1991)] |
The effects of alaproclate and p-chlorophenylalanine on cued...
1992-01-01 [J. Neural Transm. Park. Dis. Dement. Sect. 4(1) , 43-52, (1992)] |
Non-reversal of scopolamine- or age-related EEG changes by o...
1991-01-01 [Psychopharmacology 103(4) , 567-70, (1991)] |
Affinity and specificity of N-methyl- D-aspartate channel bl...
2003-02-01 [Psychopharmacology 165(4) , 378-85, (2003)] |
Effects of alaproclate, potassium channel blockers, and lido...
1989-07-01 [Pharmacol. Toxicol. 65(1) , 25-32, (1989)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved